1 Study Coverage
1.1 Therapeutic Radioisotopes Product Introduction
1.2 Market by Type
1.2.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market by Application
1.3.1 Global Therapeutic Radioisotopes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Therapeutic Radioisotopes Sales Estimates and Forecasts 2017-2028
2.2 Global Therapeutic Radioisotopes Revenue Estimates and Forecasts 2017-2028
2.3 Global Therapeutic Radioisotopes Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Therapeutic Radioisotopes Sales by Region
2.4.1 Global Therapeutic Radioisotopes Sales by Region (2017-2022)
2.4.2 Global Sales Therapeutic Radioisotopes by Region (2023-2028)
2.5 Global Therapeutic Radioisotopes Revenue by Region
2.5.1 Global Therapeutic Radioisotopes Revenue by Region (2017-2022)
2.5.2 Global Therapeutic Radioisotopes Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Therapeutic Radioisotopes Sales by Manufacturers
3.1.1 Global Top Therapeutic Radioisotopes Manufacturers by Sales (2017-2022)
3.1.2 Global Therapeutic Radioisotopes Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic Radioisotopes in 2021
3.2 Global Therapeutic Radioisotopes Revenue by Manufacturers
3.2.1 Global Therapeutic Radioisotopes Revenue by Manufacturers (2017-2022)
3.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Radioisotopes Revenue in 2021
3.3 Global Therapeutic Radioisotopes Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Therapeutic Radioisotopes Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Therapeutic Radioisotopes Sales by Type
4.1.1 Global Therapeutic Radioisotopes Historical Sales by Type (2017-2022)
4.1.2 Global Therapeutic Radioisotopes Forecasted Sales by Type (2023-2028)
4.1.3 Global Therapeutic Radioisotopes Sales Market Share by Type (2017-2028)
4.2 Global Therapeutic Radioisotopes Revenue by Type
4.2.1 Global Therapeutic Radioisotopes Historical Revenue by Type (2017-2022)
4.2.2 Global Therapeutic Radioisotopes Forecasted Revenue by Type (2023-2028)
4.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Type (2017-2028)
4.3 Global Therapeutic Radioisotopes Price by Type
4.3.1 Global Therapeutic Radioisotopes Price by Type (2017-2022)
4.3.2 Global Therapeutic Radioisotopes Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Therapeutic Radioisotopes Sales by Application
5.1.1 Global Therapeutic Radioisotopes Historical Sales by Application (2017-2022)
5.1.2 Global Therapeutic Radioisotopes Forecasted Sales by Application (2023-2028)
5.1.3 Global Therapeutic Radioisotopes Sales Market Share by Application (2017-2028)
5.2 Global Therapeutic Radioisotopes Revenue by Application
5.2.1 Global Therapeutic Radioisotopes Historical Revenue by Application (2017-2022)
5.2.2 Global Therapeutic Radioisotopes Forecasted Revenue by Application (2023-2028)
5.2.3 Global Therapeutic Radioisotopes Revenue Market Share by Application (2017-2028)
5.3 Global Therapeutic Radioisotopes Price by Application
5.3.1 Global Therapeutic Radioisotopes Price by Application (2017-2022)
5.3.2 Global Therapeutic Radioisotopes Price Forecast by Application (2023-2028)
6 North America
6.1 North America Therapeutic Radioisotopes Market Size by Type
6.1.1 North America Therapeutic Radioisotopes Sales by Type (2017-2028)
6.1.2 North America Therapeutic Radioisotopes Revenue by Type (2017-2028)
6.2 North America Therapeutic Radioisotopes Market Size by Application
6.2.1 North America Therapeutic Radioisotopes Sales by Application (2017-2028)
6.2.2 North America Therapeutic Radioisotopes Revenue by Application (2017-2028)
6.3 North America Therapeutic Radioisotopes Market Size by Country
6.3.1 North America Therapeutic Radioisotopes Sales by Country (2017-2028)
6.3.2 North America Therapeutic Radioisotopes Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Therapeutic Radioisotopes Market Size by Type
7.1.1 Europe Therapeutic Radioisotopes Sales by Type (2017-2028)
7.1.2 Europe Therapeutic Radioisotopes Revenue by Type (2017-2028)
7.2 Europe Therapeutic Radioisotopes Market Size by Application
7.2.1 Europe Therapeutic Radioisotopes Sales by Application (2017-2028)
7.2.2 Europe Therapeutic Radioisotopes Revenue by Application (2017-2028)
7.3 Europe Therapeutic Radioisotopes Market Size by Country
7.3.1 Europe Therapeutic Radioisotopes Sales by Country (2017-2028)
7.3.2 Europe Therapeutic Radioisotopes Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Therapeutic Radioisotopes Market Size by Type
8.1.1 Asia Pacific Therapeutic Radioisotopes Sales by Type (2017-2028)
8.1.2 Asia Pacific Therapeutic Radioisotopes Revenue by Type (2017-2028)
8.2 Asia Pacific Therapeutic Radioisotopes Market Size by Application
8.2.1 Asia Pacific Therapeutic Radioisotopes Sales by Application (2017-2028)
8.2.2 Asia Pacific Therapeutic Radioisotopes Revenue by Application (2017-2028)
8.3 Asia Pacific Therapeutic Radioisotopes Market Size by Region
8.3.1 Asia Pacific Therapeutic Radioisotopes Sales by Region (2017-2028)
8.3.2 Asia Pacific Therapeutic Radioisotopes Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Therapeutic Radioisotopes Market Size by Type
9.1.1 Latin America Therapeutic Radioisotopes Sales by Type (2017-2028)
9.1.2 Latin America Therapeutic Radioisotopes Revenue by Type (2017-2028)
9.2 Latin America Therapeutic Radioisotopes Market Size by Application
9.2.1 Latin America Therapeutic Radioisotopes Sales by Application (2017-2028)
9.2.2 Latin America Therapeutic Radioisotopes Revenue by Application (2017-2028)
9.3 Latin America Therapeutic Radioisotopes Market Size by Country
9.3.1 Latin America Therapeutic Radioisotopes Sales by Country (2017-2028)
9.3.2 Latin America Therapeutic Radioisotopes Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Therapeutic Radioisotopes Market Size by Type
10.1.1 Middle East and Africa Therapeutic Radioisotopes Sales by Type (2017-2028)
10.1.2 Middle East and Africa Therapeutic Radioisotopes Revenue by Type (2017-2028)
10.2 Middle East and Africa Therapeutic Radioisotopes Market Size by Application
10.2.1 Middle East and Africa Therapeutic Radioisotopes Sales by Application (2017-2028)
10.2.2 Middle East and Africa Therapeutic Radioisotopes Revenue by Application (2017-2028)
10.3 Middle East and Africa Therapeutic Radioisotopes Market Size by Country
10.3.1 Middle East and Africa Therapeutic Radioisotopes Sales by Country (2017-2028)
10.3.2 Middle East and Africa Therapeutic Radioisotopes Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Overview
11.2.3 Novartis Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Recent Developments
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Corporation Information
11.3.2 China Isotope & Radiation Overview
11.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 China Isotope & Radiation Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 China Isotope & Radiation Recent Developments
11.4 Dongcheng
11.4.1 Dongcheng Corporation Information
11.4.2 Dongcheng Overview
11.4.3 Dongcheng Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Dongcheng Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dongcheng Recent Developments
11.5 Q BioMed
11.5.1 Q BioMed Corporation Information
11.5.2 Q BioMed Overview
11.5.3 Q BioMed Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Q BioMed Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Q BioMed Recent Developments
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Corporation Information
11.6.2 Curium Pharmaceuticals Overview
11.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Curium Pharmaceuticals Recent Developments
11.7 Jubilant DraxImage
11.7.1 Jubilant DraxImage Corporation Information
11.7.2 Jubilant DraxImage Overview
11.7.3 Jubilant DraxImage Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Jubilant DraxImage Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jubilant DraxImage Recent Developments
11.8 Lantheus
11.8.1 Lantheus Corporation Information
11.8.2 Lantheus Overview
11.8.3 Lantheus Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Lantheus Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lantheus Recent Developments
11.9 Spectrum Pharmaceuticals
11.9.1 Spectrum Pharmaceuticals Corporation Information
11.9.2 Spectrum Pharmaceuticals Overview
11.9.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Spectrum Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Spectrum Pharmaceuticals Recent Developments
11.10 Progenics Pharmaceuticals
11.10.1 Progenics Pharmaceuticals Corporation Information
11.10.2 Progenics Pharmaceuticals Overview
11.10.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Progenics Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Progenics Pharmaceuticals Recent Developments
11.11 International Isotopes
11.11.1 International Isotopes Corporation Information
11.11.2 International Isotopes Overview
11.11.3 International Isotopes Therapeutic Radioisotopes Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 International Isotopes Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 International Isotopes Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Therapeutic Radioisotopes Industry Chain Analysis
12.2 Therapeutic Radioisotopes Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Therapeutic Radioisotopes Production Mode & Process
12.4 Therapeutic Radioisotopes Sales and Marketing
12.4.1 Therapeutic Radioisotopes Sales Channels
12.4.2 Therapeutic Radioisotopes Distributors
12.5 Therapeutic Radioisotopes Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Therapeutic Radioisotopes Industry Trends
13.2 Therapeutic Radioisotopes Market Drivers
13.3 Therapeutic Radioisotopes Market Challenges
13.4 Therapeutic Radioisotopes Market Restraints
14 Key Findings in The Global Therapeutic Radioisotopes Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Therapeutic Radioisotopes Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Radium-223
Table 3. Major Manufacturers of Lutetium-177
Table 4. Major Manufacturers of Iodine-131
Table 5. Major Manufacturers of Other
Table 6. Global Therapeutic Radioisotopes Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Therapeutic Radioisotopes Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Therapeutic Radioisotopes Sales by Region (2017-2022) & (K Units)
Table 9. Global Therapeutic Radioisotopes Sales Market Share by Region (2017-2022)
Table 10. Global Therapeutic Radioisotopes Sales by Region (2023-2028) & (K Units)
Table 11. Global Therapeutic Radioisotopes Sales Market Share by Region (2023-2028)
Table 12. Global Therapeutic Radioisotopes Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Therapeutic Radioisotopes Revenue Market Share by Region (2017-2022)
Table 14. Global Therapeutic Radioisotopes Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Therapeutic Radioisotopes Revenue Market Share by Region (2023-2028)
Table 16. Global Therapeutic Radioisotopes Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Therapeutic Radioisotopes Sales Share by Manufacturers (2017-2022)
Table 18. Global Therapeutic Radioisotopes Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Therapeutic Radioisotopes Revenue Share by Manufacturers (2017-2022)
Table 20. Therapeutic Radioisotopes Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Therapeutic Radioisotopes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Therapeutic Radioisotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Radioisotopes as of 2021)
Table 23. Therapeutic Radioisotopes Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Therapeutic Radioisotopes Product Offered
Table 25. Date of Manufacturers Enter into Therapeutic Radioisotopes Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Therapeutic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 28. Global Therapeutic Radioisotopes Sales by Type (2023-2028) & (K Units)
Table 29. Global Therapeutic Radioisotopes Sales Share by Type (2017-2022)
Table 30. Global Therapeutic Radioisotopes Sales Share by Type (2023-2028)
Table 31. Global Therapeutic Radioisotopes Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Therapeutic Radioisotopes Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Therapeutic Radioisotopes Revenue Share by Type (2017-2022)
Table 34. Global Therapeutic Radioisotopes Revenue Share by Type (2023-2028)
Table 35. Therapeutic Radioisotopes Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Therapeutic Radioisotopes Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Therapeutic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 38. Global Therapeutic Radioisotopes Sales by Application (2023-2028) & (K Units)
Table 39. Global Therapeutic Radioisotopes Sales Share by Application (2017-2022)
Table 40. Global Therapeutic Radioisotopes Sales Share by Application (2023-2028)
Table 41. Global Therapeutic Radioisotopes Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Therapeutic Radioisotopes Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Therapeutic Radioisotopes Revenue Share by Application (2017-2022)
Table 44. Global Therapeutic Radioisotopes Revenue Share by Application (2023-2028)
Table 45. Therapeutic Radioisotopes Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Therapeutic Radioisotopes Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Therapeutic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 48. North America Therapeutic Radioisotopes Sales by Type (2023-2028) & (K Units)
Table 49. North America Therapeutic Radioisotopes Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Therapeutic Radioisotopes Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Therapeutic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 52. North America Therapeutic Radioisotopes Sales by Application (2023-2028) & (K Units)
Table 53. North America Therapeutic Radioisotopes Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Therapeutic Radioisotopes Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Therapeutic Radioisotopes Sales by Country (2017-2022) & (K Units)
Table 56. North America Therapeutic Radioisotopes Sales by Country (2023-2028) & (K Units)
Table 57. North America Therapeutic Radioisotopes Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Therapeutic Radioisotopes Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Therapeutic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 60. Europe Therapeutic Radioisotopes Sales by Type (2023-2028) & (K Units)
Table 61. Europe Therapeutic Radioisotopes Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Therapeutic Radioisotopes Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Therapeutic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 64. Europe Therapeutic Radioisotopes Sales by Application (2023-2028) & (K Units)
Table 65. Europe Therapeutic Radioisotopes Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Therapeutic Radioisotopes Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Therapeutic Radioisotopes Sales by Country (2017-2022) & (K Units)
Table 68. Europe Therapeutic Radioisotopes Sales by Country (2023-2028) & (K Units)
Table 69. Europe Therapeutic Radioisotopes Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Therapeutic Radioisotopes Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Therapeutic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Therapeutic Radioisotopes Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Therapeutic Radioisotopes Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Therapeutic Radioisotopes Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Therapeutic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Therapeutic Radioisotopes Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Therapeutic Radioisotopes Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Therapeutic Radioisotopes Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Therapeutic Radioisotopes Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Therapeutic Radioisotopes Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Therapeutic Radioisotopes Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Therapeutic Radioisotopes Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Therapeutic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Therapeutic Radioisotopes Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Therapeutic Radioisotopes Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Therapeutic Radioisotopes Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Therapeutic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Therapeutic Radioisotopes Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Therapeutic Radioisotopes Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Therapeutic Radioisotopes Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Therapeutic Radioisotopes Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Therapeutic Radioisotopes Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Therapeutic Radioisotopes Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Therapeutic Radioisotopes Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Therapeutic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Therapeutic Radioisotopes Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Therapeutic Radioisotopes Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Therapeutic Radioisotopes Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Therapeutic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Therapeutic Radioisotopes Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Therapeutic Radioisotopes Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Therapeutic Radioisotopes Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Therapeutic Radioisotopes Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Therapeutic Radioisotopes Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Therapeutic Radioisotopes Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Therapeutic Radioisotopes Revenue by Country (2023-2028) & (US$ Million)
Table 107. Bayer Corporation Information
Table 108. Bayer Description and Major Businesses
Table 109. Bayer Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Bayer Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Bayer Recent Developments
Table 112. Novartis Corporation Information
Table 113. Novartis Description and Major Businesses
Table 114. Novartis Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Novartis Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Novartis Recent Developments
Table 117. China Isotope & Radiation Corporation Information
Table 118. China Isotope & Radiation Description and Major Businesses
Table 119. China Isotope & Radiation Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. China Isotope & Radiation Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. China Isotope & Radiation Recent Developments
Table 122. Dongcheng Corporation Information
Table 123. Dongcheng Description and Major Businesses
Table 124. Dongcheng Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Dongcheng Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Dongcheng Recent Developments
Table 127. Q BioMed Corporation Information
Table 128. Q BioMed Description and Major Businesses
Table 129. Q BioMed Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Q BioMed Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Q BioMed Recent Developments
Table 132. Curium Pharmaceuticals Corporation Information
Table 133. Curium Pharmaceuticals Description and Major Businesses
Table 134. Curium Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Curium Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Curium Pharmaceuticals Recent Developments
Table 137. Jubilant DraxImage Corporation Information
Table 138. Jubilant DraxImage Description and Major Businesses
Table 139. Jubilant DraxImage Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Jubilant DraxImage Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Jubilant DraxImage Recent Developments
Table 142. Lantheus Corporation Information
Table 143. Lantheus Description and Major Businesses
Table 144. Lantheus Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Lantheus Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Lantheus Recent Developments
Table 147. Spectrum Pharmaceuticals Corporation Information
Table 148. Spectrum Pharmaceuticals Description and Major Businesses
Table 149. Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. Spectrum Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Spectrum Pharmaceuticals Recent Developments
Table 152. Progenics Pharmaceuticals Corporation Information
Table 153. Progenics Pharmaceuticals Description and Major Businesses
Table 154. Progenics Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Progenics Pharmaceuticals Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Progenics Pharmaceuticals Recent Developments
Table 157. International Isotopes Corporation Information
Table 158. International Isotopes Description and Major Businesses
Table 159. International Isotopes Therapeutic Radioisotopes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. International Isotopes Therapeutic Radioisotopes Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. International Isotopes Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Therapeutic Radioisotopes Distributors List
Table 165. Therapeutic Radioisotopes Customers List
Table 166. Therapeutic Radioisotopes Market Trends
Table 167. Therapeutic Radioisotopes Market Drivers
Table 168. Therapeutic Radioisotopes Market Challenges
Table 169. Therapeutic Radioisotopes Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Radioisotopes Product Picture
Figure 3. Global Therapeutic Radioisotopes Market Share by Type in 2021 & 2028
Figure 3. Radium-223 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Iodine-131 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Therapeutic Radioisotopes Market Share by Application in 2021 & 2028
Figure 8. Thyroid
Figure 9. Bone Metastasis
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Therapeutic Radioisotopes Report Years Considered
Figure 13. Global Therapeutic Radioisotopes Sales 2017-2028 (K Units)
Figure 14. Global Therapeutic Radioisotopes Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Therapeutic Radioisotopes Revenue 2017-2028 (US$ Million)
Figure 16. Global Therapeutic Radioisotopes Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Therapeutic Radioisotopes Sales Market Share by Region (2017-2022)
Figure 18. Global Therapeutic Radioisotopes Sales Market Share by Region (2023-2028)
Figure 19. North America Therapeutic Radioisotopes Sales YoY (2017-2028) & (K Units)
Figure 20. North America Therapeutic Radioisotopes Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Therapeutic Radioisotopes Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Therapeutic Radioisotopes Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Therapeutic Radioisotopes Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Therapeutic Radioisotopes Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Therapeutic Radioisotopes Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Therapeutic Radioisotopes Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Therapeutic Radioisotopes Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Therapeutic Radioisotopes Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Therapeutic Radioisotopes Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Therapeutic Radioisotopes in the World: Market Share by Therapeutic Radioisotopes Revenue in 2021
Figure 31. Global Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Therapeutic Radioisotopes Sales Market Share by Type (2017-2028)
Figure 33. Global Therapeutic Radioisotopes Revenue Market Share by Type (2017-2028)
Figure 34. Global Therapeutic Radioisotopes Sales Market Share by Application (2017-2028)
Figure 35. Global Therapeutic Radioisotopes Revenue Market Share by Application (2017-2028)
Figure 36. North America Therapeutic Radioisotopes Sales Market Share by Type (2017-2028)
Figure 37. North America Therapeutic Radioisotopes Revenue Market Share by Type (2017-2028)
Figure 38. North America Therapeutic Radioisotopes Sales Market Share by Application (2017-2028)
Figure 39. North America Therapeutic Radioisotopes Revenue Market Share by Application (2017-2028)
Figure 40. North America Therapeutic Radioisotopes Sales Share by Country (2017-2028)
Figure 41. North America Therapeutic Radioisotopes Revenue Share by Country (2017-2028)
Figure 42. U.S. Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Therapeutic Radioisotopes Sales Market Share by Type (2017-2028)
Figure 45. Europe Therapeutic Radioisotopes Revenue Market Share by Type (2017-2028)
Figure 46. Europe Therapeutic Radioisotopes Sales Market Share by Application (2017-2028)
Figure 47. Europe Therapeutic Radioisotopes Revenue Market Share by Application (2017-2028)
Figure 48. Europe Therapeutic Radioisotopes Sales Share by Country (2017-2028)
Figure 49. Europe Therapeutic Radioisotopes Revenue Share by Country (2017-2028)
Figure 50. Germany Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 51. France Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Therapeutic Radioisotopes Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Therapeutic Radioisotopes Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Therapeutic Radioisotopes Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Therapeutic Radioisotopes Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Therapeutic Radioisotopes Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Therapeutic Radioisotopes Revenue Share by Region (2017-2028)
Figure 61. China Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 64. India Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Therapeutic Radioisotopes Sales Market Share by Type (2017-2028)
Figure 72. Latin America Therapeutic Radioisotopes Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Therapeutic Radioisotopes Sales Market Share by Application (2017-2028)
Figure 74. Latin America Therapeutic Radioisotopes Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Therapeutic Radioisotopes Sales Share by Country (2017-2028)
Figure 76. Latin America Therapeutic Radioisotopes Revenue Share by Country (2017-2028)
Figure 77. Mexico Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Therapeutic Radioisotopes Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Therapeutic Radioisotopes Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Therapeutic Radioisotopes Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Therapeutic Radioisotopes Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Therapeutic Radioisotopes Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Therapeutic Radioisotopes Revenue Share by Country (2017-2028)
Figure 86. Turkey Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 88. U.A.E Therapeutic Radioisotopes Revenue (2017-2028) & (US$ Million)
Figure 89. Therapeutic Radioisotopes Value Chain
Figure 90. Therapeutic Radioisotopes Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
